The human apoptosis-inducing factor (hAIF) supports OXPHOS biogenesis and programmed cell death, with missense mutations producing neurodegenerative phenotypes. hAIF senses the redox environment of cellular compartments, stabilizing a charge transfer complex (CTC) dimer that modulates the protein interaction network. In this context, we aimed to evaluate the subcellular pH, CTC formation, and pathogenic mutations effects on hAIF stability, and a thermal denaturation high-throughput screening (HTS) assay to discover AIF binders.
Results:
Apoptotic hAIFΔ1–101 is not stable at intermembrane mitochondrial space (IMS) pH, but the 77–101 residues confer stability to the mitochondrial isoform. hAIF and its CTC populate different conformational ensembles with redox switch to the CTC producing a less stable and compact protein. The pathogenic G308E, ΔR201, and E493V mutations modulate hAIF stability; particularly, ΔR201 causes a population shift to a less stable conformation that remodels active site structure and dynamics. We have identified new molecules that modulate the hAIF reduced nicotinamide adenine dinucleotide (NADH)/oxidized nicotinamide adenine dinucleotide (NAD+) association/dissociation equilibrium and regulate its catalytic efficiency.
Innovation:
Biophysical methods allow evaluating the regulation of hAIF functional ensembles and to develop an HTS assay to discover small molecules that might modulate hAIF stability and activities.
Conclusions:
The mitochondrial soluble 54–77 portion stabilizes hAIF at the IMS pH. NADH–redox-linked conformation changes course with strong NAD+ binding and protein dimerization, but they produce a negative impact in overall hAIF stability. Loss of functionality in the R201 deletion is due to distortion of the active site architecture. We report molecules that may serve as leads in the development of hAIF bioactive compounds.
Get full access to this article
View all access options for this article.
References
1.
ArdissoneA, PiscosquitoG, LegatiA, LangellaT, LamanteaE, GaravagliaB, SalsanoE, FarinaL, MoroniI, PareysonD, and GhezziD. A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disorders. Neurology, 84: 2193–2195, 2015.
2.
ArtusC, BoujradH, BouharrourA, BrunelleMN, HoosS, YusteVJ, LenormandP, RousselleJC, NamaneA, EnglandP, LorenzoHK, and SusinSA. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J, 29: 1585–1599, 2010.
3.
BaritaudM, BoujradH, LorenzoHK, KranticS, and SusinSA. Histone H2AX: The missing link in AIF-mediated caspase-independent programmed necrosis. Cell Cycle, 9: 3166–3173, 2010.
4.
BergerI, Ben-NeriahZ, Dor-WolmanT, ShaagA, SaadaA, ZenvirtS, Raas-RothschildA, NadjariM, KaestnerKH, and ElpelegO. Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing. Mol Genet Metab, 104: 517–520, 2011.
5.
BiasiniM, BienertS, WaterhouseA, ArnoldK, StuderG, SchmidtT, KieferF, Gallo CassarinoT, BertoniM, BordoliL, and SchwedeT. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res, 42: W252–W258, 2014.
6.
BrandtsJF and LinLN. Study of strong to ultratight protein interactions using differential scanning calorimetry. Biochemistry, 29: 6927–6940, 1990.
CabonL, Galán-MaloP, BouharrourA, DelavalléeL, Brunelle-NavasMN, LorenzoHK, GrossA, and SusinSA. BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. Cell Death Differ, 19: 245–256, 2012.
10.
CandéC, VahsenN, KourantiI, SchmittE, DaugasE, SpahrC, LubanJ, KroemerRT, GiordanettoF, GarridoC, PenningerJM, and KroemerG. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene, 23: 1514–1521, 2004.
11.
ChanLL, PinedaM, HeeresJT, HergenrotherPJ, and CunninghamBT. A general method for discovering inhibitors of protein-DNA interactions using photonic crystal biosensors. ACS Chem Biol, 3: 437–448, 2008.
12.
CorteseJD, VoglinoAL, and HackenbrockCR. Ionic strength of the intermembrane space of intact mitochondria as estimated with fluorescein-BSA delivered by low pH fusion. J Cell Biol, 113: 1331–1340, 1991.
13.
CremadesN, Velázquez-CampoyA, Martínez-JúlvezM, NeiraJL, Pérez-DoradoI, HermosoJ, JiménezP, LanasA, HoffmanPS, and SanchoJ. Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection. ACS Chem Biol, 4: 928–938, 2009.
14.
DelanoWL. The PyMOL Molecular Graphics System . San Carlos, CA:. DeLano Scientific,. 2002.
15.
DiodatoD, TascaG, VerrigniD, D'AmicoA, RizzaT, TozziG, MartinelliD, VerardoM, InvernizziF, NascaA, BellacchioE, GhezziD, PiemonteF, Dionisi-ViciC, CarrozzoR, and BertiniE. A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease. Eur J Hum Genet, 24: 463–466, 2016.
16.
FarinaB, Di SorboG, ChamberyA, CaporaleA, LeoniG, RussoR, MascanzoniF, RaimondoD, FattorussoR, RuvoM, and DotiN. Structural and biochemical insights of CypA and AIF interaction. Sci Rep, 7: 1138, 2017.
17.
FerreiraP, VillanuevaR, Martínez-JulvezM, and MedinaM. Apoptosis-Inducing Factor 1, Mitochondrion-associated, 1. In: Encyclopedia of Signaling Molecules, edited by ChoiS.Cham, Switzerland: Springer, 2018, pp. 361–366.
18.
FerreiraP, VillanuevaR, Martínez-JúlvezM, HerguedasB, MarcuelloC, Fernandez-SilvaP, CabonL, HermosoJA, LostaoA, SusinSA, and MedinaM. Structural insights into the coenzyme mediated monomer-dimer transition of the pro-apoptotic apoptosis inducing factor. Biochemistry, 53: 4204–4215, 2014.
19.
FornerisF, OrruR, BoniventoD, ChiarelliLR, and MatteviA. ThermoFAD, a Thermofluor-adapted flavin ad hoc detection system for protein folding and ligand binding. FEBS J, 276: 2833–2840, 2009.
GerstingSW, KemterKF, StaudiglM, MessingDD, DaneckaMK, LaglerFB, SommerhoffCP, RoscherAA, and MuntauAC. Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am J Hum Genet, 83: 5–17, 2008.
22.
GhezziD, SevrioukovaI, InvernizziF, LampertiC, MoraM, D'AdamoP, NovaraF, ZuffardiO, UzielG, and ZevianiM. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am J Hum Genet, 86: 639–649, 2010.
23.
GrimmeS, EhrlichS, and GoerigkL. Effect of the damping function in dispersion corrected density functional theory. J Comput Chem, 32: 1456–1465, 2011.
24.
GurbuxaniS, SchmittE, CandeC, ParcellierA, HammannA, DaugasE, KourantiI, SpahrC, PanceA, KroemerG, and GarridoC. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene, 22: 6669–6678, 2003.
JonesG, WillettP, GlenRC, LeachAR, and TaylorR. Development and validation of a genetic algorithm for flexible docking. J Mol Biol, 267: 727–748, 1997.
29.
KadamAA, JubinT, MirHA, and BegumR. Potential role of Apoptosis Inducing Factor in evolutionarily significant eukaryote, Dictyostelium discoideum survival. Biochim Biophys Acta, 1861: 2942–2955, 2017.
30.
KettwigM, SchubachM, ZimmermannFA, KlingeL, MayrJA, BiskupS, SperlW, GärtnerJ, and HuppkeP. From ventriculomegaly to severe muscular atrophy: expansion of the clinical spectrum related to mutations in AIFM1. Mitochondrion, 21: 12–18, 2015.
31.
Kuban-JankowskaA, SahuKK, NiedzialkowskiP, GorskaM, TuszynskiJA, OssowskiT, and WozniakM. Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis. Oncotarget, 6: 18364–18373, 2015.
32.
LagorceD, SperandioO, BaellJB, MitevaMA, and VilloutreixBO. FAF-Drugs3: a web server for compound property calculation and chemical library design. Nucleic Acids Res, 43: W200–W207, 2015.
33.
Le GuillouxV, SchmidtkeP, and TufferyP. Fpocket: an open source platform for ligand pocket detection. BMC Bioinformatics, 10: 168, 2009.
34.
LeeMS, SalsburyFR, and BrooksCL. Novel generalized Born Methods. J Chem Phy, 116: 10606–10614, 2002.
35.
LipinskiCA, LombardoF, DominyBW, and FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46: 3–26, 2001.
36.
LlopisJ, McCafferyJM, MiyawakiA, FarquharMG, and TsienRY. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc Natl Acad Sci U S A, 95: 6803–6808, 1998.
37.
LuiJC and KongSK. Heat shock protein 70 inhibits the nuclear import of apoptosis-inducing factor to avoid DNA fragmentation in TF-1 cells during erythropoiesis. FEBS Lett, 581: 109–117, 2007.
38.
LópezLC, Dos-ReisS, EspargaróA, CarrodeguasJA, MaddeleinML, VenturaS, and SanchoJ. Discovery of novel inhibitors of amyloid β-peptide 1–42 aggregation. J Med Chem, 55: 9521–9530, 2012.
39.
MatsuyamaS, LlopisJ, DeverauxQL, TsienRY, and ReedJC. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol, 2: 318–325, 2000.
40.
Medina-CarmonaE, NeiraJL, SalidoE, FuchsJE, Palomino-MoralesR, TimsonDJ, and PeyAL. Site-to-site interdomain communication may mediate different loss-of-function mechanisms in a cancer-associated NQO1 polymorphism. Sci Rep, 7: 44532, 2017.
41.
MeyerK, BuettnerS, GhezziD, ZevianiM, BanoD, and NicoteraP. Loss of apoptosis-inducing factor critically affects MIA40 function. Cell Death Dis, 6: e1814, 2015.
ModjtahediN, GiordanettoF, MadeoF, and KroemerG. Apoptosis-inducing factor: vital and lethal. Trends Cell Biol, 16: 264–272, 2006.
44.
MortonSU, PrabhuSP, LidovHGW, ShiJ, AnselmI, BrownsteinCA, BainbridgeMN, BeggsAH, VargasSO, and AgrawalPB. AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant. Cold Spring Harb Mol Case Stud, 3, 2017.
45.
NatarajanSK and BeckerDF. Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress. Cell Health Cytoskelet, 2012: 11–27, 2012.
46.
OlssonMHM, SøndergaardCR, RostkowskiM, and JensenJH. PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. J Chem Theory Comput, 7: 525–537, 2011.
47.
OrijR, PostmusJ, Ter BeekA, BrulS, and SmitsGJ. In vivo measurement of cytosolic and mitochondrial pH using a pH-sensitive GFP derivative in Saccharomyces cerevisiae reveals a relation between intracellular pH and growth. Microbiology, 155: 268–278, 2009.
48.
OteraH, OhsakayaS, NagauraZ, IshiharaN, and MiharaK. Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. EMBO J, 24: 1375–1386, 2005.
49.
PorcelliAM, GhelliA, ZannaC, PintonP, RizzutoR, and RugoloM. pH difference across the outer mitochondrial membrane measured with a green fluorescent protein mutant. Biochem Biophys Res Commun, 326: 799–804, 2005.
50.
RinaldiC, GrunseichC, SevrioukovaIF, SchindlerA, Horkayne-SzakalyI, LampertiC, LandouréG, KennersonML, BurnettBG, BönnemannC, BieseckerLG, GhezziD, ZevianiM, and FischbeckKH. Cowchock syndrome is associated with a mutation in apoptosis-inducing factor. Am J Hum Genet, 91: 1095–1102, 2012.
51.
SanchoJ. The stability of 2-state, 3-state and more-state proteins from simple spectroscopic techniques… plus the structure of the equilibrium intermediates at the same time. Arch Biochem Biophys, 531: 4–13, 2013.
52.
SanchoP, Sánchez-MonteagudoA, ColladoA, Marco-MarínC, Domínguez-GonzálezC, CamachoA, KnechtE, EspinósC, and LupoV. A newly distal hereditary motor neuropathy caused by a rare AIFM1 mutation. Neurogenetics, 18: 245–250, 2017.
53.
SchmittE, ParcellierA, GurbuxaniS, CandeC, HammannA, MoralesMC, HuntCR, DixDJ, KroemerRT, GiordanettoF, JäätteläM, PenningerJM, PanceA, KroemerG, and GarridoC. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant. Cancer Res, 63: 8233–8240, 2003.
54.
SeksekO and BolardJ. Nuclear pH gradient in mammalian cells revealed by laser microspectrofluorimetry. J Cell Sci 109 (Pt 1): 257–262, 1996.
SevrioukovaIF. Structure/Function Relations in AIFM1 Variants Associated with Neurodegenerative Disorders. J Mol Biol, 428: 3650–3665, 2016.
58.
ShelarSB, KaminskaKK, ReddySA, KumarD, TanCT, YuVC, LuJ, HolmgrenA, HagenT, and ChewEH. Thioredoxin-dependent regulation of AIF-mediated DNA damage. Free Radic Biol Med, 87: 125–136, 2015.
59.
ShendureJ and AkeyJM. The origins, determinants, and consequences of human mutations. Science, 349: 1478–1483, 2015.
60.
ShrakeA and RossPD. Origins and consequences of ligand-induced multiphasic thermal protein denaturation. Biopolymers, 32: 925–940, 1992.
61.
SorrentinoL, CalogeroAM, PandiniV, VanoniMA, SevrioukovaIF, and AlivertiA. Key Role of the Adenylate Moiety and Integrity of the Adenylate-Binding Site for the NAD(+)/H Binding to Mitochondrial Apoptosis-Inducing Factor. Biochemistry, 54: 6996–7009, 2015.
62.
SorrentinoL, CossuF, MilaniM, AlivertiA, and MastrangeloE. Structural bases of the altered catalytic properties of a pathogenic variant of apoptosis inducing factor. Biochem Biophys Res Commun, 490: 1011–1017, 2017.
63.
SteinA, WhitlockJP, and BinaM. Acidic polypeptides can assemble both histones and chromatin in vitro at physiological ionic strength. Proc Natl Acad Sci U S A, 76: 5000–5004, 1979.
TsiCJ, ChaoY, ChenCW, and LinWW. Aurintricarboxylic acid protects against cell death caused by lipopolysaccharide in macrophages by decreasing inducible nitric-oxide synthase induction via IkappaB kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase inhibition. Mol Pharmacol, 62: 90–101, 2002.
VanommeslaegheK, HatcherE, AcharyaC, KunduS, ZhongS, ShimJ, DarianE, GuvenchO, LopesP, VorobyovI, and MackerellAD. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem, 31: 671–690, 2010.
68.
Velazquez-CampoyA, SanchoJ, AbianO, and VegaS. Biophysical screening for identifying pharmacological chaperones and inhibitors against conformational and infectious diseases. Curr Drug Targets, 17: 1492–1505, 2016.
69.
WangY, KimNS, HainceJF, KangHC, DavidKK, AndrabiSA, PoirierGG, DawsonVL, and DawsonTM. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci Signal, 4: ra20, 2011.
70.
XieH, VuceticS, IakouchevaLM, OldfieldCJ, DunkerAK, UverskyVN, and ObradovicZ. Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J Proteome Res, 6: 1882–1898, 2007.
71.
YeH, CandeC, StephanouNC, JiangS, GurbuxaniS, LarochetteN, DaugasE, GarridoC, KroemerG, and WuH. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol, 9: 680–684, 2002.
72.
ZhangY, HanT, ZhuQ, ZhangW, BaoW, FuHJ, YangJ, HuangXJ, WeiJX, MengYL, ZhaoJ, CaoYX, JiaLT, and YangiAG. The proapoptotic activity of C-terminal domain of apoptosis-inducing factor (AIF) is separated from its N-terminal. Biol Res, 42: 249–260, 2009.
73.
ZhuC, WangX, DeinumJ, HuangZ, GaoJ, ModjtahediN, NeaguMR, NilssonM, ErikssonPS, HagbergH, LubanJ, KroemerG, and BlomgrenK. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med, 204: 1741–1748, 2007.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
